Totally Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Totally has been growing earnings at an average annual rate of 27.4%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 7.2% per year.
Belangrijke informatie
27.4%
Groei van de winst
46.5%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 12.6% |
| Inkomstengroei | 7.2% |
| Rendement op eigen vermogen | -9.3% |
| Nettomarge | -2.9% |
| Volgende winstupdate | 06 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Totally plc's (LON:TLY) Share Price Boosted 48% But Its Business Prospects Need A Lift Too
Aug 02
Is Totally (LON:TLY) Using Debt In A Risky Way?
Jul 26Totally plc (LON:TLY) Stock Catapults 65% Though Its Price And Business Still Lag The Industry
May 08Totally plc's (LON:TLY) Shares Bounce 54% But Its Business Still Trails The Industry
Feb 17These 4 Measures Indicate That Totally (LON:TLY) Is Using Debt Extensively
Feb 06Estimating The Intrinsic Value Of Totally plc (LON:TLY)
Sep 02Is Totally (LON:TLY) A Risky Investment?
Jul 11Is There An Opportunity With Totally plc's (LON:TLY) 45% Undervaluation?
Apr 20Is Totally plc (LON:TLY) Potentially Undervalued?
Sep 06Totally's (LON:TLY) Promising Earnings May Rest On Soft Foundations
Nov 22At UK£0.36, Is It Time To Put Totally plc (LON:TLY) On Your Watch List?
Nov 17Shareholders Will Probably Hold Off On Increasing Totally plc's (LON:TLY) CEO Compensation For The Time Being
Aug 31An Intrinsic Calculation For Totally plc (LON:TLY) Suggests It's 50% Undervalued
Jul 16How Much Is Totally plc (LON:TLY) CEO Getting Paid?
Feb 03Does Totally's (LON:TLY) Share Price Gain of 63% Match Its Business Performance?
Dec 08Opbrengsten en kosten
Hoe Totally geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 24 | 107 | -3 | 16 | 0 |
| 31 Dec 23 | 114 | -2 | 17 | 0 |
| 30 Sep 23 | 121 | -1 | 18 | 0 |
| 30 Jun 23 | 128 | 0 | 18 | 0 |
| 31 Mar 23 | 136 | 2 | 18 | 0 |
| 31 Dec 22 | 136 | 1 | 18 | 0 |
| 30 Sep 22 | 136 | 1 | 17 | 0 |
| 30 Jun 22 | 132 | 1 | 17 | 0 |
| 31 Mar 22 | 127 | 1 | 17 | 0 |
| 31 Dec 21 | 124 | 1 | 17 | 0 |
| 30 Sep 21 | 121 | 1 | 17 | 0 |
| 30 Jun 21 | 117 | 1 | 17 | 0 |
| 31 Mar 21 | 114 | 0 | 16 | 0 |
| 31 Dec 20 | 112 | 0 | 16 | 0 |
| 30 Sep 20 | 111 | 0 | 15 | 0 |
| 30 Jun 20 | 108 | -2 | 15 | 0 |
| 31 Mar 20 | 106 | -3 | 15 | 0 |
| 31 Dec 19 | 97 | -3 | 14 | 0 |
| 30 Sep 19 | 87 | -3 | 13 | 0 |
| 30 Jun 19 | 83 | -2 | 12 | 0 |
| 31 Mar 19 | 78 | -2 | 11 | 0 |
| 30 Sep 18 | 71 | 2 | 9 | 0 |
| 30 Jun 18 | 52 | 2 | 7 | 0 |
| 31 Mar 18 | 34 | 1 | 5 | 0 |
| 31 Dec 17 | 21 | -2 | 6 | 0 |
| 30 Sep 17 | 14 | -2 | 5 | 0 |
| 30 Jun 17 | 7 | -2 | 4 | 0 |
| 31 Mar 17 | 5 | -2 | 3 | 0 |
| 31 Dec 16 | 4 | -2 | 3 | 0 |
| 30 Sep 16 | 3 | -1 | 2 | 0 |
| 30 Jun 16 | 1 | -1 | 1 | 0 |
| 31 Mar 16 | 1 | -1 | 1 | 0 |
| 31 Dec 15 | 1 | 0 | 1 | 0 |
| 30 Sep 15 | 1 | 0 | 1 | 0 |
| 30 Jun 15 | 1 | 0 | 1 | 0 |
| 31 Mar 15 | 1 | 0 | 1 | 0 |
| 31 Dec 14 | 1 | 0 | 1 | 0 |
| 30 Jun 14 | 0 | -1 | 1 | 0 |
| 31 Mar 14 | 1 | -1 | 1 | 0 |
| 31 Dec 13 | 1 | -1 | 1 | 0 |
Kwaliteitswinsten: TLY is currently unprofitable.
Groeiende winstmarge: TLY is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: TLY is unprofitable, but has reduced losses over the past 5 years at a rate of 27.4% per year.
Versnelling van de groei: Unable to compare TLY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: TLY is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (12.1%).
Rendement op eigen vermogen
Hoge ROE: TLY has a negative Return on Equity (-9.29%), as it is currently unprofitable.